CD86 and COVID-19: Activation marker CD86 expression was reduced in pre‐13 days COVID‐19 derived EVs compared to both healthy controls and post‐13 days COVID‐19 derived EVs, suggesting serum EVs from pre‐13 days suppress B cells activation.